litlas
ログインアカウント作成

Douglas S. Robinson

1992–2024 年に発表

65
論文数
19,695
被引用数
60
h 指数
65
i10 指数

被引用数

Douglas S. Robinson の年別被引用数1933 年: 被引用 1 件1979 年: 被引用 1 件1992 年: 被引用 10 件1993 年: 被引用 47 件1994 年: 被引用 52 件1995 年: 被引用 73 件1996 年: 被引用 76 件1997 年: 被引用 84 件1998 年: 被引用 155 件1999 年: 被引用 258 件2000 年: 被引用 270 件2001 年: 被引用 283 件2002 年: 被引用 181 件2003 年: 被引用 225 件2004 年: 被引用 214 件2005 年: 被引用 220 件2006 年: 被引用 229 件2007 年: 被引用 222 件2008 年: 被引用 240 件2009 年: 被引用 274 件2010 年: 被引用 256 件2011 年: 被引用 198 件2012 年: 被引用 174 件2013 年: 被引用 144 件2014 年: 被引用 121 件2015 年: 被引用 123 件2016 年: 被引用 100 件2017 年: 被引用 122 件2018 年: 被引用 84 件2019 年: 被引用 297 件2020 年: 被引用 312 件2021 年: 被引用 270 件2022 年: 被引用 198 件2023 年: 被引用 148 件2024 年: 被引用 187 件2025 年: 被引用 112 件2026 年: 被引用 1 件1934〜1978 年は被引用が無いため表示していません1980〜1991 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,895 件、この内訳の 27.7%イギリス: 引用元論文 811 件、この内訳の 11.8%日本: 引用元論文 392 件、この内訳の 5.7%カナダ: 引用元論文 355 件、この内訳の 5.2%イタリア: 引用元論文 325 件、この内訳の 4.7%ドイツ: 引用元論文 306 件、この内訳の 4.5%中国: 引用元論文 276 件、この内訳の 4%オーストラリア: 引用元論文 260 件、この内訳の 3.8%フランス: 引用元論文 259 件、この内訳の 3.8%オランダ: 引用元論文 195 件、この内訳の 2.8%ベルギー: 引用元論文 178 件、この内訳の 2.6%スイス: 引用元論文 172 件、この内訳の 2.5%
0%27.7%その他 20.9%

機関

分野

  • Medicine68.8%
  • Immunology and Microbiology20.2%
  • Biochemistry, Genetics and Molecular Biology6.6%
  • Neuroscience1%
  • Environmental Science0.9%
  • Agricultural and Biological Sciences0.6%
  • その他1.9%

トピック

  • Asthma and respiratory diseases20.3%
  • IL-33, ST2, and ILC Pathways7.3%
  • Allergic Rhinitis and Sensitization6.5%
  • Immune Cell Function and Interaction5.6%
  • Respiratory and Cough-Related Research4.1%
  • T-cell and B-cell Immunology3.8%
  • その他52.4%

共著者

全論文

検索で開く
  1. Thymic Stromal Lymphopoietin Expression Is Increased in Asthmatic Airways and Correlates with Expression of Th2-Attracting Chemokines and Disease Severity

    著者: Sun Ying, Brian O’Connor, Jonathan Ratoff, Qiu Meng, Kirsty Mallett, David J. Cousins, Douglas S. Robinson, Guizhen Zhang, Jisheng Zhao, TH Lee, Christopher J. Corrigan - The Journal of Immunology 2005 被引用: 860

  2. Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics

    著者: Patrick Flood-Page, Andrew Menzies‐Gow, Simon Phipps, Ying Sun, A Wangoo, Mara S. Ludwig, Neil Barnes, Douglas S. Robinson, A.B. Kay - Journal of Clinical Investigation 2003 被引用: 842

  3. Revisiting Type 2‐high and Type 2‐low airway inflammation in asthma: current knowledge and therapeutic implications

    著者: Douglas S. Robinson, Marc Humbert, Roland Buhl, Álvaro A. Cruz, Hiromasa Inoue, Stephan Korom, Nicola A. Hanania, Parameswaran Nair - Clinical & Experimental Allergy 2016 被引用: 377

  4. A Study to Evaluate Safety and Efficacy of Mepolizumab in Patients with Moderate Persistent Asthma

    著者: Patrick Flood-Page, Cheri A. Swenson, Isidore Faiferman, John G. Matthews, Michael Williams, Lesley Brannick, Douglas S. Robinson, Sally E. Wenzel, William W. Busse, Trevor T. Hansel, Neil Barnes - American Journal of Respiratory and Critical Care Medicine 2007 被引用: 745

  5. Predominant TH2-like Bronchoalveolar T-Lymphocyte Population in Atopic Asthma

    著者: Douglas S. Robinson, Qutayba Hamid, Sun Ying, Anne Tsicopoulos, J Barkans, Andrew Bentley, Christopher J. Corrigan, Stephen R. Durham, A.B. Kay - New England Journal of Medicine 1992 被引用: 2,766

  6. Eosinophil's Role Remains Uncertain as Anti–Interleukin-5 only Partially Depletes Numbers in Asthmatic Airway

    著者: Patrick Flood-Page, Andrew Menzies‐Gow, A B Kay, Douglas S. Robinson - American Journal of Respiratory and Critical Care Medicine 2003 被引用: 809

  7. Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4 + CD25 + regulatory T cells is interleukin 10 dependent

    著者: Jennifer Kearley, Jane E. Barker, Douglas S. Robinson, Clare M. Lloyd - The Journal of Experimental Medicine 2005 被引用: 515

  8. Composite type-2 biomarker strategy versus a symptom–risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial

    著者: Liam G. Heaney, John Busby, Catherine E. Hanratty, Ratko Djukanović, Ashley Woodcock, Samantha Walker, Timothy C. Hardman, Joseph R. Arron, David F. Choy, Peter Bradding, Christopher E. Brightling, Rekha Chaudhuri, Douglas C. Cowan, Adel Mansur, Stephen J. Fowler, Robert Niven, Peter Howarth, James Lordan, Andrew Menzies‐Gow, Tim Harrison, Douglas S. Robinson, Cécile Holweg, John G. Matthews, Ian Pavord, Ian M. Adcock, Adnam Azim, Mary Bellamy, Catherine Borg, Michelle Bourne, Clare Connolly, Richard W. Costello, Christopher J. Corrigan, Sarah Davies, Gareth Davies, Kian Fan Chung, Gabrielle Gainsborough, Traceyanne Grandison, Beverley Hargadon, A. Van Horn, Val Hudson, David J. Jackson, Sebastian L. Johnston, Geraldine Jones, Paula McCourt, María del Rocío Guillen Núñez, Dominick Shaw, Katherine Smith, Joel Solis, Roisin Stone, Freda Yang - The Lancet Respiratory Medicine 2020 被引用: 137

  9. Relationship between inflammatory status and microbial composition in severe asthma and during exacerbation

    著者: Sarah Diver, Koirobi Haldar, P. Jane McDowell, John Busby, Vijay Mistry, Claudia Micieli, Vanessa Brown, Ciara Cox, Freda Yang, Catherine Borg, Rahul Shrimanker, Mohammadali Yavari Ramsheh, Timothy C. Hardman, Joseph R. Arron, Peter Bradding, Douglas C. Cowan, Adel Mansur, Stephen J. Fowler, Jim Lordan, Andrew Menzies‐Gow, Douglas S. Robinson, John G. Matthews, Ian Pavord, Rekha Chaudhuri, Liam G. Heaney, Michael R. Barer, Christopher E. Brightling - Allergy 2022 被引用: 33

  10. Anti–IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics

    著者: Andrew Menzies‐Gow, Patrick Flood-Page, Roma Sehmi, John Burman, Qutayba Hamid, Douglas S. Robinson, A B Kay, Judah A. Denburg - Journal of Allergy and Clinical Immunology 2003 被引用: 275

  11. Exacerbation Profile and Risk Factors in a Type-2–Low Enriched Severe Asthma Cohort: A Clinical Trial to Assess Asthma Exacerbation Phenotypes

    著者: P. Jane McDowell, John Busby, Catherine E. Hanratty, Ratko Djukanović, Ashley Woodcock, Samantha Walker, Timothy C. Hardman, Joseph R. Arron, David F. Choy, Peter Bradding, Christopher E. Brightling, Rekha Chaudhuri, Douglas C. Cowan, Adel Mansur, Stephen J. Fowler, Sarah Diver, Peter Howarth, James Lordan, Andrew Menzies‐Gow, Timothy Harrison, Douglas S. Robinson, Cécile Holweg, John G. Matthews, Ian Pavord, Liam G. Heaney - American Journal of Respiratory and Critical Care Medicine 2022 被引用: 86

  12. A Randomized Trial of a Composite T2-Biomarker Strategy Adjusting Corticosteroid Treatment in Severe Asthma: A Post Hoc Analysis by Sex

    著者: M. Eastwood, John Busby, David J. Jackson, Ian Pavord, Catherine E. Hanratty, Ratko Djukanović, Ashley Woodcock, Samantha Walker, Timothy C. Hardman, Joseph R. Arron, David F. Choy, Peter Bradding, Christopher E. Brightling, Rekha Chaudhuri, Douglas C. Cowan, Adel Mansur, Stephen J. Fowler, Peter Howarth, James Lordan, Andrew Menzies‐Gow, Timothy Harrison, Douglas S. Robinson, Cécile Holweg, John G. Matthews, Liam G. Heaney - The Journal of Allergy and Clinical Immunology In Practice 2023 被引用: 23

  13. IGIF Does Not Drive Th1 Development but Synergizes with IL-12 for Interferon-γ Production and Activates IRAK and NFκB

    著者: Douglas S. Robinson, Kazuko Shibuya, Alice Mui, Francesca Zonin, Erin Murphy, Theo Sana, Suzanne B. Hartley, Satish Menon, Rob Kastelein, Fernando Bazán, Anne O’Garra - Immunity 1997 被引用: 723

  14. Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease

    著者: Eleanor Ling, Trevor R. F. Smith, X Dao Nguyen, Carol Pridgeon, Margaret J. Dallman, Justine Arbery, V. A. Carr, Douglas S. Robinson - The Lancet 2004 被引用: 740

  15. A role for eosinophils in airway remodelling in asthma

    著者: A.B. Kay, Simon Phipps, Douglas S. Robinson - Trends in Immunology 2004 被引用: 336

  16. Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co‐localization of eotaxin mRNA to bronchial epithelial and endothelial cells

    著者: Ying Sun, Douglas S. Robinson, Qiu Meng, James B. Rottman, Russ Kennedy, D J Ringler, Charles R. Mackay, Bruce L. Daugherty, Martin S. Springer, Stephen R. Durham, Timothy J. Williams, A.B. Kay - European Journal of Immunology 1997 被引用: 425

  17. Parameters associated with persistent airflow obstruction in chronic severe asthma

    著者: Dragoș Bumbăcea, Donald Campbell, Lan Tien Nguyen, Denis H. Carr, Peter J. Barnes, Douglas S. Robinson, Kian Fan Chung - European Respiratory Journal 2004 被引用: 243

  18. Differential Regulation of Human Eosinophil IL-3, IL-5, and GM-CSF Receptor α-Chain Expression by Cytokines: IL-3, IL-5, and GM-CSF Down-Regulate IL-5 Receptor α Expression with Loss of IL-5 Responsiveness, but Up-Regulate IL-3 Receptor α Expression

    著者: Bernard Gregory, Antje Kirchem, Simon Phipps, Philippe Gevaert, Carol Pridgeon, Sara M. Rankin, Douglas S. Robinson - The Journal of Immunology 2003 被引用: 131

  19. SomaLogic proteomics reveals new biomarkers and provides mechanistic, clinical insights into Acetyl coA Carboxylase (ACC) inhibition in Non-alcoholic Steatohepatitis (NASH)

    著者: Pitchumani Sivakumar, Michelle Saul, Douglas S. Robinson, Lindsay E. King, Neeta B. Amin - Scientific Reports 2024 被引用: 14

  20. Basophils, eosinophils, and mast cells in atopic and nonatopic asthma and in late-phase allergic reactions in the lung and skin

    著者: Alison Macfarlane, Onn Min Kon, Susan J. Smith, Kyriaki Zeibecoglou, Lubna Khan, Luís Taborda‐Barata, Alan R. McEuen, Mark G. Buckley, Andrew F. Walls, Qiu Meng, Marc Humbert, Neil Barnes, Douglas S. Robinson, Sun Ying, A.B. Kay - Journal of Allergy and Clinical Immunology 2000 被引用: 202

  21. Omalizumab treats chronic rhinosinusitis with nasal polyps and asthma together-a real life study

    著者: Therese Bidder, Jagdeep Sahota, C. Rennie, Valerie J. Lund, Douglas S. Robinson, Harsha H. Kariyawasam - Rhinology Journal 2018 被引用: 89

  22. Development and Function of T Helper 1 Cells

    著者: Anne O’Garra, Douglas S. Robinson - Advances in immunology 2004 被引用: 84

  23. Biomarker Predictors of Clinical Efficacy of the Anti-IgE Biologic Omalizumab in Severe Asthma in Adults: Results of the SoMOSA Study

    著者: Ratko Djukanović, Paul Brinkman, Johan Kolmert, Cristina Gómez, James Schofield, Joost Brandsma, Andy Shapanis, Paul Skipp, Anthony D. Postle, Craig E. Wheelock, Sven-Erik Dahlen, Peter J. Sterk, Thomas Brown, David J. Jackson, Adel Mansur, Ian Pavord, Mitesh Patel, Christopher E. Brightling, Salman Siddiqui, Peter Bradding, Ian Sabroe, Dinesh Saralaya, Livingstone Chishimba, Joanna C. Porter, Douglas S. Robinson, Stephen J. Fowler, Peter Howarth, Louisa Little, Thomas Oliver, Kayleigh Hill, Louise Stanton, Allen Alexander, Deborah A. Ellis, Gareth Griffiths, Tim Harrison, Ayobami Akenroye, Jessica Lasky‐Su, Liam G. Heaney, Rekha Chaudhuri, Ramesh Kurukulaaratchy - American Journal of Respiratory and Critical Care Medicine 2024 被引用: 24

  24. The role of T lymphocytes in the pathogenesis of asthma

    著者: Mark Larché, Douglas S. Robinson, A.B. Kay - Journal of Allergy and Clinical Immunology 2003 被引用: 572